Page 51 Opióides

91. Bruera E, Schoeller T, Montejo G. Organic hallucinosis in patients receiving high doses of opiates for
cancer pain. Pain 1992;48(3):397-9.
92. Thangathurai D, Bowles HF, Allen HW, et al. The incidence of pruritus after epidural morphine (letter).
Anaesthesia 1988;43(12):1055-6.
93. Abel EL. Opiates and sex. J Psychoactive Drugs 1984;16(3):205-16.
94. Cousins MJ, Mather LE. Intrathecal and epidural administration of opioids. Anesthesiology 1984;
61:276-310.
95. Dray A. Epidural opiates and urinary retention: new models provide new insights. Anesthesiology
1988;68(3):323-4.
96. Moulin DE, Kreeft JH, Murray-Parsons N, et al. Comparison of continuous subcutaneous and intrave-
nous hydromorphone infusion for management of cancer pain. Lancet 1991;337(8739):465-8.
97. Rawal M, Möllefors K, Axelsson K, et al. An experimental study of urodynamic effects of epidural
morphine and of naloxone reversal. Anesth Analg 1983;62:641-7.
98. Eisele JH Jr, Grigsby EJ, Dea G. Clonazepam treatment of mvoclonic contractions associated with
high-dose opioids: a case report. Pain 1992;49:231-2.
99. Roman DJ, Jeffrey E, Jacqueline GN, et al. Use of opioid analgesics for the treatment of chronic
noncancer pain – A consensus statement and guidelines from the Canadian Pain Society. Pain Re-
search and Management 1998;3(4):3-13.
100. Inturrisi CE. Clinical Pharmacology of Opioid Analgesics. Anesth Clin of North Am 1989;7(1):33-49.
101. Nishikawa K, Tanobe K, Hinohara H, et al. Molecular mechanism of morphine tolerance and biologi-
cal approaches to resolve tolerance. Masui 2004;53(5):502-7.
102. Portenoy RK, Moulin DE, Rogers A, et al. IV infusion of opioids for cancer pain: Clinical review and
guidelines for use. Cancer Treat Rep 1986;70:575-81.
103. Portenoy RK, Payne R. Acute and chronic pain. Em: Lowinson JH, Ruiz P, Millman RB, editors.
nd
Substance abuse: a comprehensive textbook. 2 ed. Baltimore: Williams & Wilkins 1992;691-721.
104. Ozaki S, Narita M, Suzuki T. Basic research for psychological dependence on morphine under chron-
ic pain. Nippon Rinsho 2001 Sep;59(9):1704-12.
105. Jaffe JH. Drug addiction and drug abuse. Em: Gilman AG, Goodman LS, Rawll TW, Murad F, eds. The
Pharmacological Basis of Therapeutics, ed. 7. New York: Macmillan, 1985;532-81.
106. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med 1980;302:123.
Letter.
107. Noda Y, Mamiya T, Nabeshima T. The mechanisms of morphine dependence and it’s withdrawal
syndrome: study in mutant mice. Nippon Yakurigaku Zasshi 2001;117(1):21-6.
108. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine:
an evidence-based report. J Clin Oncol 2001 May 1;19(9):2542-54.

48